Literature DB >> 28945308

An autopsy-based study of Trypanosoma cruzi persistence in organs of chronic chagasic patients and its relevance for transplantation.

Luiz A Benvenuti1, Alessandra Roggério1, Marta M Cavalcanti1, Anna S Nishiya2, José E Levi2.   

Abstract

BACKGROUND: Chagas' disease (CD) is caused by infection with the protozoan Trypanosoma cruzi. The disease can affect the heart and/or the gastrointestinal (GI) tract, but around 70% of infected individuals remain asymptomatic in the chronic form. Organ transplantation from T. cruzi-infected donors is often avoided because of the risk of disease transmission, previously reported after heart, kidney, or liver transplantation.
METHODS: We investigated by histology, immunohistochemistry, and polymerase chain reaction (PCR) the persistence of T. cruzi in samples of the heart, lung, liver, kidney, pancreas, adrenal gland, esophagus, and GI tract of 21 chronic chagasic patients.
RESULTS: Parasite persistence was detected in 12/21 (57.1%) heart samples, mainly by PCR-based assays. T. cruzi parasites were detected by histology and immunohistochemistry in smooth muscle cells of the central vein from 1/21 (4.8%) adrenal gland samples. No samples of the lung, liver, kidney, pancreas, esophagus, or GI tract were found to have parasites by histology, immunohistochemistry, or PCR.
CONCLUSIONS: We concluded that, aside from the heart, the other solid organs of T. cruzi-infected donors can be used for transplantation with a lot of caution. Such organs are not safe in the view of previous reports of CD transmission, but seem to present a low T. cruzi load compared to the heart.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Trypanosoma cruzizzm321990; Chagas' disease; autopsy; transplantation

Mesh:

Substances:

Year:  2017        PMID: 28945308     DOI: 10.1111/tid.12783

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  5 in total

Review 1.  Chagas Disease in the United States: a Public Health Approach.

Authors:  Caryn Bern; Louisa A Messenger; Jeffrey D Whitman; James H Maguire
Journal:  Clin Microbiol Rev       Date:  2019-11-27       Impact factor: 26.132

2.  The Impact of the CTHRSSVVC Peptide Upon Experimental Models of Trypanosoma cruzi Infection.

Authors:  Gabriela Rodrigues Leite; Denise da Gama Jaén Batista; Ana Lia Mazzeti; Rosemeire Aparecida Silva; Ademar Benévolo Lugão; Maria de Nazaré Correia Soeiro
Journal:  Front Cell Infect Microbiol       Date:  2022-05-06       Impact factor: 6.073

Review 3.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

4.  CD8low T cells expanded following acute Trypanosoma cruzi infection and benznidazole treatment are a relevant subset of IFN-γ producers.

Authors:  Alessandro Marins-Dos-Santos; Bianca Perdigão Olivieri; Rafaella Ferreira-Reis; Juliana de Meis; Andrea Alice Silva; Tania C de Araújo-Jorge; Joseli Lannes-Vieira; Vinicius Cotta-de-Almeida
Journal:  PLoS Negl Trop Dis       Date:  2020-12-21

5.  In Vivo Analysis of Trypanosoma cruzi Persistence Foci at Single-Cell Resolution.

Authors:  Alexander I Ward; Michael D Lewis; Archie A Khan; Conor J McCann; Amanda F Francisco; Shiromani Jayawardhana; Martin C Taylor; John M Kelly
Journal:  mBio       Date:  2020-08-04       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.